The creation of Genbiotech, a spinoff of the Laboratoires Genévrier results of 15 years of strategic involvement in biotechnological research with one goal: to improve the quality of life of...
Go to the page now
The creation of Genbiotech, a spinoff of the Laboratoires Genévrier results of 15 years of strategic involvement in biotechnological research with one goal: to improve the quality of life of...
Go to the page nowOur primary fields of interest are rheumatology, dermatology and gynecology. We have many ongoing projects in these fields and have already marketed one product in gynecology called Endocell...
Go to the page nowThe biotechnology facility consist of 330m2 controlled atmosphere area (B class, ISO5). Small and mid size clean rooms are available and can be dedicated to a specific product or production step.
Go to the page nowThe main sponsors of Genbiotech are the Laboratoires Genévrier. Genbiotech has recently received a grant from Oséo to finance its research and development on the dermatology project (GBT013) on...
Go to the page nowThe GENBIOTECH team wish you an happy new year.
Read moreGENBIOTECH will be present at the "CPHI Worldwide" in Madrid
Read moreGENBIOTECH at the Intermeditech in Paris
Read moreGENBIOTECH at the 20th Microencapsulation Industrial Convention
Read moreGENBIOTECH at the BIO-EUROPE SPRING in Barcelona
Read moreGenbiotech is strengthening its investment on its unique encapsulation device
Read moreAn article from GENBIOTECH's team has been published in Jacobs Journal of Clinical Trial
Read moreGenbiotech will be present on the "Village des sciences et de l'innovation" in Antibes Juan-Les-Pins
Read moreJournal of wound care 2016 Jul 2;25(7):406-13
Read moreGENBIOTECH announces the participation...
Read moreGenbiotech and TxCell announced the signing of a two years partnership agreement for the use of a part of its class B facilities.
Read more